Beyond the Diagnosis: Youth-focused Strategies and Solutions
Dec 3, 2024
Diagnosing and treating youth, especially for STIs, requires physicians to strike a balance of clinical expertise and empathy.
Our team of ophthalmologists, surgeons, optometrists, orthoptists, nurse practitioners and certified ophthalmic technicians is dedicated to providing the best possible care for your child's eye or vision condition.
Dec 3, 2024
Diagnosing and treating youth, especially for STIs, requires physicians to strike a balance of clinical expertise and empathy.
Dec 3, 2024
An eating disorder diagnosis may only be part of the story when a malnourished youth comes under your care. Here are other diagnoses to consider.
Dec 3, 2024
As with other mental health issues, substance use disorder (SUD) can be diagnosed in primary care. Management can include prescribing medications to treat SUD.
Dec 3, 2024
Recognizing and eliminating the “adultification” of young Black helps allow these patients to experience a full childhood. Physicians need to provide culturally sensitive care.
Dec 3, 2024
The evidence is clear: Available immunization methods work to protect infants from respiratory syncytial virus (RSV). Here’s the scoop.
Dec 3, 2024
See the latest news on research on prominent hires from Children’s Hospital of Philadelphia.
Dec 3, 2024
Transplant nurse practitioner Sonya Lopez reflects on her 30-year career with CHOP and the Pediatric Kidney Transplant and Dialysis Program’s milestone of 500 transplants.
Nov 26, 2024
In a recent study, researchers at Children’s Hospital of Philadelphia (CHOP) demonstrated that children treated for brain tumors face persistent social challenges, including limited friendships and reduced peer acceptance, extending into adulthood. The study is the first to link disruptions in white matter connectivity to impaired social functioning in survivors of pediatric brain tumors.
Nov 25, 2024
Study identified a drug for potential use in future precision medicine clinical trials
Dec 3, 2024
CHOP’s Leukodystrophy Center, one of the leading centers of its kind in the nation, now offers Lenmeldy to treat children with metachromatic leukodystrophy (MLD).